Objectives: To determine the extent to which homosexual men dying of t
he acquired immunodeficiency syndrome (AIDS) receive medication intend
ed to hasten death. To assess the impact on caregivers of administerin
g medications intended to hasten death. Methods: In a prospective stud
y of caregiving partners of men with AIDS (n = 140), characteristics o
f the ill partner, the caregiver, and the relationship were assessed a
t baseline and 1 month before the ill partner's death. Three months af
ter the death, caregivers were asked if they had increased their partn
er's narcotic and/or sedative-hypnotic medication dose and if so, what
had been the objective of the increase, and their comfort with their
medication decisions. Results: Of 140 ill partners who died of AIDS, 1
7 (12.1%) received an increase in the use of medications immediately b
efore death intended to hasten death. Diagnoses and care needs of ill
partners who received increases in the use of medications to hasten de
ath did not differ from those of ill partners receiving medication for
symptoms. Fourteen increases (10%) in use of medications were adminis
tered by caregivers. These caregivers did not differ from those admini
stering medication for symptom control in level of distress, caregivin
g burden, relationship characteristics, or comfort with the medication
decision, but they reported more social support and positive meaning
in caregiving. Conclusion: The decision to hasten death is not a rare
event in this group of men. There is no evidence that it is the result
of caregiver distress, poor relationship quality, or intolerable care
giving burden; and it does not cause excessive discomfort in the survi
ving partner. This study, although small, has implications for the pol
icy debate on assisted suicide.